AGP Picks
View all

The Latin American Examiner
Provided by AGP

The Latin American Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Latin American Examiner.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on August 3, 2026

Altimmune Initiates PERFORMA Phase 3 Trial of Pemvidutide in Patients with MASH
Aug. 3, 2026

Altimmune Initiates PERFORMA Phase 3 Trial of Pemvidutide in Patients with MASH

Indeterminate GlobeNewswire
BridgeBio to Report Second Quarter 2026 Financial Results and Commercial Updates on August 10, 2026 at 4:30 pm ET
Aug. 3, 2026

BridgeBio to Report Second Quarter 2026 Financial Results and Commercial Updates on August 10, 2026 at 4:30 pm ET

Indeterminate GlobeNewswire
Crescent Biopharma Announces Grants of Inducement Awards
Aug. 3, 2026

Crescent Biopharma Announces Grants of Inducement Awards

Indeterminate GlobeNewswire
BingX Appoints Kevin Lee as Chief Strategy Officer to Accelerate its Multi-Asset, User-Centric Vision
Aug. 3, 2026

BingX Appoints Kevin Lee as Chief Strategy Officer to Accelerate its Multi-Asset, User-Centric Vision

Indeterminate GlobeNewswire
Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health
Aug. 3, 2026

Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health

Indeterminate GlobeNewswire
Ocular Therapeutix™ Reports Second Quarter 2026 Financial Results and Business Highlights
Aug. 3, 2026

Ocular Therapeutix™ Reports Second Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire
Supernus Announces Second Quarter 2026 Financial Results
Aug. 3, 2026

Supernus Announces Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance
Aug. 3, 2026

Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance

Indeterminate GlobeNewswire
Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
Aug. 3, 2026

Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale

Indeterminate GlobeNewswire
Bitget Lists 2U2.ai (2U2) for Spot Trading
Aug. 3, 2026

Bitget Lists 2U2.ai (2U2) for Spot Trading

Indeterminate GlobeNewswire
Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses
Aug. 3, 2026

Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses

Indeterminate GlobeNewswire
Leads Biolabs' PD-L1/4-1BB Bispecific Antibody IND Application for Combination Therapy in Metastatic Colorectal Cancer Approved, Further Strengthening Gastrointestinal Oncology Franchise
Aug. 3, 2026

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody IND Application for Combination Therapy in Metastatic Colorectal Cancer Approved, Further Strengthening Gastrointestinal Oncology Franchise

Indeterminate GlobeNewswire
Vocalbeats.AI Joins AGI Playground Singapore as Strategic Partner
Aug. 3, 2026

Vocalbeats.AI Joins AGI Playground Singapore as Strategic Partner

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Latin American Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.